EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Tunable Biased Signaling of the Angiotensin II Type 1 Receptor for Inotropy via C-Terminal Peptide Engineering and Allosteric Site Targeting

Margot Hadjadj, Malihe Hassanzadeh, Justin Martel, Marie-Frédérique Roy, Hugo Giguère, Alexandre Murza iD, Brian J Holleran, Yoon Namkung, Ulrike Froehlich, Richard Leduc, Mannix Auger-Messier, Stéphane A Laporte iD und 1 weitere

Journal of Medicinal Chemistry · 2026

DOI: 10.1021/acs.jmedchem.5c01259 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Margot Hadjadj und 12 weiteren Autor:innen. Beteiligte Einrichtung: Département de Pharmacologie-Physiologie, Faculté de Médecine et des Sciences de la Santé, Centre de Recherche du CHUS, Université de Sherbrooke, She…. Hauptthemen laut MEDLINE: Receptor, Angiotensin, Type 1, Signal Transduction, Angiotensin II, Peptides. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research, Fonds de Recherche du Qu?bec - Sant?, Universit? de Sherbrooke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The angiotensin II (AngII) type 1 receptor (AT1R) is a key prototypical G protein-coupled receptor in cardiovascular regulation. Biased agonists activating G protein or β-arrestin pathways offer therapeutic promise, but the molecular determinants of this signaling bias and its physiological implications remain poorly understood. This study profiles AngII analogs with C-terminal Phe8 modifications, identifies compounds 11, 12, and 29a as exhibiting differential Gαq activation while retaining potent β-arrestin recruitment. Notably, 12 with low levels of Gαq activity, enhances left ventricular ejection fraction with limited pressor responses in normotensive rats. In contrast, other analogs with variably superior Gαq activity do not promote inotropy. Molecular modeling suggests that the flexible side chain of 12 accesses a deep allosteric pocket within AT1R, driving its unique signaling profile. This study demonstrates that engineering AngII's C-terminus enables selective tuning of AT1R signaling to control arterial versus cardiac responses, providing strategies for developing improved cardiovascular therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptor, Angiotensin, Type 1Signal TransductionAngiotensin IIPeptidesAnimalsRatsAllosteric SiteHumansModels, MolecularMaleProtein Engineeringbeta-ArrestinsRats, Sprague-Dawley

Substanzen

Receptor, Angiotensin, Type 1Angiotensin IIbeta-ArrestinsPeptides

Autor:innen und Institutionen

  • Département de Pharmacologie-Physiologie, Faculté de Médecine et des Sciences de la Santé, Centre de Recherche du CHUS, Université de Sherbrooke, Sherbrooke, Québec J1H 5N4, Canada.
  • Département de Médecine─Service de Cardiologie, Faculté de Médecine et des Sciences de la Santé, Centre de Recherche du CHUS, Université de Sherbrooke, Sherbrooke, Québec J1H 5N4, Canada.
  • Institut de Pharmacologie de Sherbrooke, Sherbrooke, Québec J1H 5N4, Canada.
  • Department of Medicine, Research Institute of the McGill University Health Center (RI-MUHC), McGill University, Montréal, Québec H4A 3J1, Canada.
  • Department of Pharmacology and Therapeutics, McGill University, Montréal, Québec H3G 1Y6, Canada.

ORCID-Profile: Alexandre Murza, Stéphane A Laporte, Pierre-Luc Boudreault

Förderung

  • Canadian Institutes of Health Research
  • Fonds de Recherche du Qu?bec - Sant?
  • Universit? de Sherbrooke

Zitieren

APA

Hadjadj, M., Hassanzadeh, M., Martel, J., Roy, M. F., Giguère, H., Murza, A., Holleran, B. J., Namkung, Y., Froehlich, U., Leduc, R., Auger-Messier, M., Laporte, S. A., & Boudreault, P. L. (2026). Tunable Biased Signaling of the Angiotensin II Type 1 Receptor for Inotropy via C-Terminal Peptide Engineering and Allosteric Site Targeting. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c01259

Vancouver

Hadjadj M, Hassanzadeh M, Martel J, Roy MF, Giguère H, Murza A, et al. Tunable Biased Signaling of the Angiotensin II Type 1 Receptor for Inotropy via C-Terminal Peptide Engineering and Allosteric Site Targeting. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.5c01259

BibTeX
@article{Hadjadj2026,
  author = {Hadjadj, Margot and Hassanzadeh, Malihe and Martel, Justin and Roy, Marie-Frédérique and Giguère, Hugo and Murza, Alexandre and Holleran, Brian J and Namkung, Yoon and Froehlich, Ulrike and Leduc, Richard and Auger-Messier, Mannix and Laporte, Stéphane A and Boudreault, Pierre-Luc},
  title = {Tunable Biased Signaling of the Angiotensin II Type 1 Receptor for Inotropy via C-Terminal Peptide Engineering and Allosteric Site Targeting},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.5c01259}
}
Kostenlos starten →